Kiniksa Pharmaceuticals (KNSA.US) Stock Community - Hot Topic Discussions

Quote List Quote List

Event Tracking

Nov18

Jefferies analyst maintains buy rating on Kiniksa Pharmaceuticals with a target price of $58

14:32

Oct30

Kiniksa Pharmaceuticals International plc CFO Sells Common Stock

20:47

Oct28

Kiniksa Pharmaceuticals released FY2025 9 Months Earnings on October 28 During-Market (EST), with actual revenue of USD 475.44 M and EPS of USD 0.57

20:00

Kiniksa Pharmaceuticals released FY2025 Q3 earnings on October 28 During-Market EST, actual revenue USD 180.86 M (forecast USD 167.36 M), actual EPS USD 0.23 (forecast USD 0.3053)

20:00

Oct21

Kiniksa Pharmaceuticals to Release FY2025 Q3 Earnings on October 28 During-Market (EST), Forecast Revenue USD 167.36 M, EPS USD 0.3069

00:05

Oct17

Kiniksa Pharmaceuticals' Drug KPL-387 Receives FDA Orphan Drug Designation

12:57

Schedules & Filings

Schedules

Filings

Oct28

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 180.86 M, Net Income 18.44 M, EPS 0.23

Jul29

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 156.8 M, Net Income 17.83 M, EPS 0.23

Apr29

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 137.79 M, Net Income 8.539 M, EPS 0.11

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change